| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for …
Over the last 12 months, insiders at Eledon Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Eledon Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Eledon Pharmaceuticals, Inc. have bought $3.05M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,927,937 shares for transaction amount of $4.57M was made by BVF PARTNERS L P/IL (10 percent owner) on 2024‑05‑09.
| 2024-05-09 | BVF PARTNERS L P/IL | 10 percent owner | 1.93M 7.8677% | $2.37 | $4.57M | +29.58% | ||
| 2023-05-05 | BVF PARTNERS L P/IL | 10 percent owner | 1.98M 11.9399% | $2.31 | $4.57M | -41.79% | ||
| 2022-11-23 | Perrin Steven | President | 1,000 0.0072% | $2.60 | $2,597 | -23.11% | ||
| 2021-12-20 | Gros David-Alexandre C | Chief Executive Officer | 2,000 0.0135% | $4.48 | $8,960 | -30.07% | ||
| 2021-08-17 | Gros David-Alexandre C | Chief Executive Officer | 4,000 0.0262% | $6.21 | $24,840 | -39.06% | ||
| 2021-06-11 | Little Paul Sean | CHIEF FINANCIAL OFFICER | 10,000 0.0681% | $8.87 | $88,700 | -46.53% | ||
| 2021-06-09 | Gros David-Alexandre C | Chief Executive Officer | 3,000 0.0203% | $8.01 | $24,030 | -40.88% | ||
| 2020-12-02 | Sale | OrbiMed Israel GP Ltd. | 10 percent owner | 103,200 6.5689% | $21.60 | $2.23M | -63.07% | |
| 2020-10-30 | Sale | Logos Global Management LP | 10 percent owner | 12,969 0.9094% | $26.64 | $345,559 | -62.38% | |
| 2020-10-30 | Logos Global Management LP | 10 percent owner | 92,040 6.1626% | $25.44 | $2.34M | -62.38% | ||
| 2019-05-21 | Sale | FLESHER GREGORY J. | Chief Executive Officer | 2,937 0.025% | $1.91 | $5,614 | -66.49% | |
| 2019-05-21 | Sale | TURKEL CATHERINE C. | President | 1,914 0.0163% | $1.91 | $3,658 | -66.49% | |
| 2019-05-21 | Sale | Kuwahara Jon | See Remarks | 1,058 0.009% | $1.91 | $2,022 | -66.49% | |
| 2019-05-20 | Sale | FLESHER GREGORY J. | Chief Executive Officer | 11,701 0.1045% | $1.96 | $22,953 | -65.78% | |
| 2019-05-20 | Sale | TURKEL CATHERINE C. | President | 7,623 0.068% | $1.96 | $14,953 | -65.78% | |
| 2019-05-20 | Sale | Kuwahara Jon | See Remarks | 4,218 0.0377% | $1.96 | $8,274 | -65.78% | |
| 2019-05-02 | OrbiMed Israel GP Ltd. | 646,204 6.2443% | $3.10 | $2M | -76.19% | |||
| 2019-05-02 | Chimovits Erez | director | 646,204 6.2443% | $3.10 | $2M | -76.19% | ||
| 2019-04-30 | Sale | LIFESCI INDEX PARTNERS LLC | 10 percent owner | 200 0.0017% | $2.70 | $540 | -75.47% | |
| 2018-09-12 | TURKEL CATHERINE C. | President | 16,632 0.1711% | $5.02 | $83,476 | -44.40% |
| Harrison Seth Loring | 7912079 9.7366% | $20.73M | 1 | 0 | ||
| Novartis Bioventures Ltd | 10 percent owner | 4493458 5.5297% | $11.77M | 1 | 9 | |
| Apple Tree Partners II - Annex, L.P. | 3568438 4.3913% | $9.35M | 1 | 0 | ||
| BVF PARTNERS L P/IL | 10 percent owner | 3361803 4.137% | $8.81M | 2 | 0 | <0.0001% |
| Chimovits Erez | director | 3183314 3.9174% | $8.34M | 1 | 0 | <0.0001% |
| Satter Muneer A | 10 percent owner | 1771688 2.1802% | $4.64M | 1 | 0 | |
| Logos Global Management LP | 10 percent owner | 224071 0.2757% | $587,066.02 | 1 | 1 | <0.0001% |
| FLESHER GREGORY J. | Chief Executive Officer | 156918 0.1931% | $411,125.16 | 1 | 2 | |
| TURKEL CATHERINE C. | President | 88662 0.1091% | $232,294.44 | 4 | 2 | <0.0001% |
| OrbiMed Israel GP Ltd. | 10 percent owner | 73650 0.0906% | $192,963.00 | 1 | 1 | <0.0001% |
| OCAMPO CHRISTINE | See Remarks | 21590 0.0266% | $56,565.80 | 1 | 0 | |
| Buckley Stephen Jr. | director | 11000 0.0135% | $28,820.00 | 2 | 0 | |
| Little Paul Sean | CHIEF FINANCIAL OFFICER | 10000 0.0123% | $26,200.00 | 1 | 0 | <0.0001% |
| Gros David-Alexandre C | Chief Executive Officer | 9000 0.0111% | $23,580.00 | 3 | 0 | <0.0001% |
| Perrin Steven | President | 1000 0.0012% | $2,620.00 | 1 | 0 | <0.0001% |
$22,710,871 | 107 | 8.53% | $220.62M | |
$6,146,922 | 96 | -4.70% | $233.68M | |
$168,352,523 | 35 | 13.58% | $218.79M | |
$74,231,875 | 30 | 40.62% | $183.78M | |
$54,828,550 | 26 | -13.88% | $201.12M |
| Increased Positions | 63 | +70% | 18M | +49.9% |
| Decreased Positions | 37 | -41.11% | 11M | -28.98% |
| New Positions | 31 | New | 12M | New |
| Sold Out Positions | 20 | Sold Out | 10M | Sold Out |
| Total Postitions | 116 | +28.89% | 44M | +20.92% |
| Bvf Inc/Il | $10,195.00 | 8.39% | 6.29M | 0 | 0% | 2025-09-30 |
| Ra Capital Management, L.P. | $5,777.00 | 4.76% | 3.57M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $5,613.00 | 4.62% | 3.47M | +210,930 | +6.48% | 2025-09-30 |
| Vanguard Group Inc | $5,294.00 | 4.36% | 3.27M | -50,600 | -1.52% | 2025-09-30 |
| Siren, L.L.C. | $3,358.00 | 2.76% | 2.07M | +1M | +200.33% | 2025-09-30 |
| Zimmer Partners, Lp | $2,957.00 | 2.43% | 1.82M | +844,318 | +86.09% | 2025-09-30 |
| Geode Capital Management, Llc | $2,218.00 | 1.83% | 1.37M | -15,000 | -1.08% | 2025-09-30 |
| Wellington Management Group Llp | $2,080.00 | 1.71% | 1.28M | +1M | New | 2025-09-30 |
| Sphera Funds Management Ltd. | $2,074.00 | 1.71% | 1.28M | -679,377 | -34.67% | 2025-09-30 |
| Ensign Peak Advisors, Inc | $2,049.00 | 1.69% | 1.26M | 0 | 0% | 2025-09-30 |